Abstract:Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne emerging phlebovirus with high mortality rates of 6.0 to 30%. SFTSV infection is characterized by high fever, thrombocytopenia, leukopenia, hemorrhage and multiple organ failures. Currently, specific therapies and vaccines remain elusive. Suitable small animal models are urgently needed to elucidate the pathogenesis and evaluate the potential drug and vaccine for SFTSV infection. Previous models presented only mild or no pathogenesis of SFTS, limiting their applications in SFTSV infection. Therefore, it is an urgent need to develop a small animal model for the investigation of SFTSV pathogenesis and evaluation of therapeutics. In the current report, we developed a SFTSV infection model based on the HuPBL-NCG mice that recapitulates many pathological characteristics of SFTSV infection in humans. Virus-induced histopathological changes were identified in spleen, lung, kidney, and liver. SFTSV was colocalized with macrophages in the spleen and liver, suggesting that the macrophages in the spleen and liver could be the principle target cells of SFTSV. In addition, histological analysis showed that the vascular endothelium integrity was severely disrupted upon viral infection along with depletion of platelets. In vitro cellular assays further revealed that SFTSV infection increased the vascular permeability of endothelial cells by promoting tyrosine phosphorylation and internalization of the adhesion molecule vascular endothelial (VE)-cadherin, a critical component of endothelial integrity. In addition, we found that both virus infection and pathogen-induced exuberant cytokine release dramatically contributed to the vascular endothelial injury. We elucidated the pathogenic mechanisms of hemorrhage syndrome and developed a humanized mouse model for SFTSV infection, which should be helpful for anti-SFTSV therapy and pathogenesis study.Author summary SFTSV is a novel bunyavirus that was identified in 2010 and endemic in China, Korea, Japan and Vietnam with expanding spatial incidents. SFTS is characterized by high case-fatality rates and currently has no effective therapeutics or vaccines. In previous study, models presented only mild or no pathogenesis of SFTS, limiting their applications in SFTSV infection. In the current study, we developed a humanized NCG mouse model for the study of SFTSV infection and elucidated the pathogenic mechanisms of hemorrhage syndrome with respect to apoptosis, membrane protein endocytosis and cytokine stimulation. The HuPBL-NCG model presented multiple organ pathologies that resemble those of human infection, which will be helpful for anti-SFTSV therapy and pathogenesis study.

Nonmuscle Myosin Heavy Chain IIA is a Critical Factor Contributing to the Efficiency of Early Infection of Severe Fever with Thrombocytopenia Syndrome Virus

Expression of Structural and Non-Structural Proteins of Severe Fever with Thrombocytopenia Syndrome Bunyavirus

Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation.

The pathogenesis of SFTSV infection in IFN g / く knockout mice : 1 insights into the pathologic mechanisms of a new viral hemorrhagic 2 fever

Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection

Pathogenesis of Emerging Severe Fever with Thrombocytopenia Syndrome Virus in C57/BL6 Mouse Model.

Nonstructural Protein NSs Hampers Cellular Antiviral Response Through LSm14A During Severe Fever with Thrombocytopenia Syndrome Virus Infection.

Structure of Severe Fever with Thrombocytopenia Syndrome Virus Nucleocapsid Protein in Complex with Suramin Reveals Therapeutic Potential.

The Pathogenesis Of Severe Fever With Thrombocytopenia Syndrome Virus Infection In Alpha/Beta Interferon Knockout Mice: Insights Into The Pathologic Mechanisms Of A New Viral Hemorrhagic Fever

Nucleocapsid Protein-Specific IgM Antibody Responses in the Disease Progression of Severe Fever with Thrombocytopenia Syndrome

Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome

Non-structural Proteins of Severe Fever With Thrombocytopenia Syndrome Virus Suppress RNA Synthesis in a Transcriptionally Active cDNA-Derived Viral RNA Synthesis System

The Nucleoprotein of Severe Fever with Thrombocytopenia Syndrome Virus Processes a Stable Hexameric Ring to Facilitate RNA Encapsidation

A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection

Effect of Genomic Variations in Severe Fever with Thrombocytopenia Syndrome Virus on the Disease Lethality

Bunyavirus SFTSV nucleoprotein exploits tufm-mediated mitophagy to impair antiviral innate immunity

SFTS Phlebovirus Promotes LC3-II Accumulation and Nonstructural Protein of SFTS Phlebovirus Co-Localizes with Autophagy Proteins.

Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses

Cryo-EM Structure of Severe Fever with Thrombocytopenia Syndrome Virus

Infection Of Humanized Mice With A Novel Phlebovirus Presented Pathogenic Features Of Sever Fever With Thrombocytopenia Syndrome

Characterization of severe fever with thrombocytopenia syndrome virus Japanese isolate YG1 strain quasispecies using reverse genetics approaches